ADVANCED NEUROENDOCRINE CARCINOMA
Clinical trials for ADVANCED NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare cancer
Disease control Recruiting nowThis study is testing a new drug called LBL-024 combined with standard chemotherapy (etoposide and platinum) as a first treatment for people with advanced neuroendocrine carcinoma (NEC), a rare and aggressive cancer. About 178 adults aged 18-75 will take part. The goal is to see …
Matched conditions: ADVANCED NEUROENDOCRINE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves the overall experience. About 220 participants will be randomly assigned to receive their t…
Matched conditions: ADVANCED NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC